Monitor the next quarter's revenue and adjusted EPS for continued momentum in high-value products and GLP-1 demand, which are key drivers of the raised guidance.
Price Chart
Executive Summary
West Pharmaceutical Services reported strong Q1 2026 results with revenue of $844.9M (+21.0% YoY) and adjusted EPS of $2.13 (+46.9% YoY), significantly beating consensus. The company raised its full-year 2026 revenue guidance to $3.295B-$3.350B and adjusted EPS guidance to $8.40-$8.75, driven by strong organic growth in high-value products and GLP-1 demand.
Key Financial Metrics
Key Facts
- Q1 2026 revenue: $844.9M, +21.0% YoY (+15.3% organic)
- Q1 2026 adjusted EPS: $2.13, +46.9% YoY
- Raised full-year 2026 revenue guidance to $3.295B-$3.350B (from $3.215B-$3.275B)
- Raised full-year 2026 adjusted EPS guidance to $8.40-$8.75 (from $7.85-$8.20)
- Repurchased 1.2M shares for $297.6M during Q1
Financial Impact
$844.9M revenue, $2.13 adjusted EPS
Risk Factors
- Currency fluctuations could impact reported revenue growth
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000105770-26-000047 |
| Document: wst-20260423.htm | 0000105770-26-000047 |
| Document: a1q26earningsdeck-final.htm | 0000105770-26-000047 |
| Document: 0000105770-26-000047-index-headers.html | 0000105770-26-000047 |
| Document: 0000105770-26-000047-index.html | 0000105770-26-000047 |
| Document: 0000105770-26-000047.txt | 0000105770-26-000047 |
| 8-K Data (Synthetic) | 0000105770-26-000047 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 23, 2026 10w ago | 8-K | $355.48 $353.77 | ▼ −0.48% | ▼ −3.79% | $364.89 (+2.65%) |
Jul 23, 2026 10w ago | Press Release | $355.48 $353.77 | ▼ −0.48% | ▼ −3.79% | $364.89 (+2.65%) |
Jul 7, 2026 12w ago | Press Release | $356.08 $347.94 | ▼ −2.29% | ▼ −3.62% | $364.89 (+2.47%) |
May 11, 2026 20w ago | 8-K | $311.82 $330.92 | ▼ −6.12% | ▼ −7.85% | $364.89 (−17.02%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access